Cognitive Decline May Come Earlier for People With Epilepsy

Follow Drugslib on

Medically reviewed by Melisa Puckey, BPharm. Last updated on Dec 5, 2023.

By Dennis Thompson HealthDay Reporter

TUESDAY, Dec. 5, 2023 -- People with epilepsy suffer quicker declines in thinking than people without the brain disorder, particularly if they also have risk factors like high blood pressure or diabetes, a new study finds.

The difference was significant: Over the course of the 14-year study, those with epilepsy experienced a 65% to 70% faster decline in memory and thinking skills.

On top of that, having risk factors for heart disease pushed that percentage 20% higher.

“While epilepsy itself is associated with [mild cognitive impairment] and dementia, this risk is substantially magnified in those who also have high blood pressure, diabetes or other cardiovascular risk factors,” said lead researcher Dr. Ifrah Zawar, an assistant professor of neurology at the University of Virginia in Charlottesville.

Researchers said their study is unique because it tracked the transition to mild cognitive impairment and dementia in more than 13,700 people who started the study with healthy brains.

The participants were recruited at 39 Alzheimer’s disease centers across the United States between September 2005 and December 2021. Fewer than 1% had epilepsy, researchers said.

The rate of decline from mild cognitive impairment to dementia was the same in patients with or without epilepsy. The researchers speculate that’s probably because heart risk factors play a much bigger role than epilepsy in the later stages of dementia.

The findings were presented Friday at the American Epilepsy Society annual meeting in Orlando, Fla. Such research should be considered preliminary until published in a peer-reviewed journal.

“It is important to identify epilepsy promptly and treat it aggressively, to help slow or prevent this decline in older adults who are cognitively healthy,” Zawar said in a meeting news release. “In addition, early screening and targeted interventions towards modifiable cardiovascular risk factors may also help delay the onset of dementia.”

Sources

  • American Epilepsy Society, news release, Dec. 1, 2023

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2023-12-06 04:37

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords